http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103356684-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103356684-B
titleOfInvention Houttuynoid E is preparing the application in medicament for expanding vascellum
abstract Does the present invention improve Houttuynoid? is E preparing the application in medicament for expanding vascellum, described Houttuynoid? application in the angiopathy medicines such as E reduces blood pressure in preparation, antianginal.The Houttuynoid that the present invention relates to? E belongs to first public preparing the purposes in medicament for expanding vascellum, because framework types belongs to brand-new framework types, its extension vessel activity is unexpectedly strong, there is not the possibility being provided any enlightenment by other compounds, possessing outstanding substantive distinguishing features, for expanding blood vessel, obviously there is significant progress simultaneously.
priorityDate 2013-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555633
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6082

Total number of triples: 18.